• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性肝病和非酒精性脂肪性肝病患者的遗传背景差异。

Differences in the genetic backgrounds of patients with alcoholic liver disease and non-alcoholic fatty liver disease.

作者信息

Yamamoto Kuniko, Kogiso Tomomi, Taniai Makiko, Hashimoto Etsuko, Tokushige Katsutoshi

机构信息

Institute of Gastroenterology, Department of Internal Medicine Tokyo Women's Medical University Tokyo Japan.

出版信息

JGH Open. 2018 Oct 17;3(1):17-24. doi: 10.1002/jgh3.12097. eCollection 2019 Feb.

DOI:10.1002/jgh3.12097
PMID:30834336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6386744/
Abstract

BACKGROUND AND AIM

Alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) have common hepatic histological features, but few studies have compared the genomic backgrounds of these two diseases. Here, we compared the genetic differences between ALD and NAFLD.

METHODS

This study enrolled 318 Japanese patients with ALD ( = 118; male, 86%; median age, 62 years; liver cirrhosis, 58%; hepatocellular carcinoma [HCC], 31%) and NAFLD ( = 200; male, 55%; age, 61 years; cirrhosis, 19%; HCC, 12%). The genotype frequencies of 10 single nucleotide polymorphisms (SNPs) were analyzed.

RESULTS

The genotype GG and genotype GG were observed more frequently, and the percentage of patients with the genotype GG was lower in ALD compared with NAFLD patients (, 16 4%; 84 44%; 62 72%, respectively; all  < 0.01). Comparing noncirrhosis to cirrhosis, the frequency of the potassium voltage-gated channel subfamily Q member 1 () genotype TT and adrenoceptor beta 3 () genotype TT was increased significantly in ALD-related cirrhosis. In contrast, the patatin-like phospholipase 3 () genotype CC was decreased significantly in NAFLD-related cirrhosis. A comparison of patients with and without HCC demonstrated that the genotype TT was increased significantly in both HCC groups. In addition, associations between the genotype GG and ALD-HCC and the G allele of and NAFLD-HCC were identified.

CONCLUSIONS

SNPs in genes related to ethanol and lipid metabolism clearly differed between patients with ALD and NAFLD. KCNQ1 might affect the progression and hepatocarcinogenesis in both ALD and NAFLD.

摘要

背景与目的

酒精性肝病(ALD)和非酒精性脂肪性肝病(NAFLD)具有共同的肝脏组织学特征,但很少有研究比较这两种疾病的基因组背景。在此,我们比较了ALD和NAFLD之间的遗传差异。

方法

本研究纳入了318例日本ALD患者(n = 118;男性,86%;中位年龄,62岁;肝硬化,58%;肝细胞癌[HCC],31%)和NAFLD患者(n = 200;男性,55%;年龄,61岁;肝硬化,19%;HCC,12%)。分析了10个单核苷酸多态性(SNP)的基因型频率。

结果

GG基因型和 基因型GG观察到的频率更高,与NAFLD患者相比,ALD患者中 基因型GG的患者百分比更低(分别为16±4%、84±44%、62±72%;均P<0.01)。将非肝硬化与肝硬化进行比较,在ALD相关肝硬化中,钾电压门控通道亚家族Q成员1(KCNQ1)基因型TT和肾上腺素能受体β3(ADRB3)基因型TT的频率显著增加。相反,在NAFLD相关肝硬化中,帕他汀样磷脂酶3(PNPLA3)基因型CC显著降低。对有和无HCC的患者进行比较表明,在两个HCC组中 基因型TT均显著增加。此外,还确定了 基因型GG与ALD-HCC以及 的G等位基因与NAFLD-HCC之间的关联。

结论

ALD和NAFLD患者中与乙醇和脂质代谢相关基因的SNP明显不同。KCNQ1可能影响ALD和NAFLD的进展及肝癌发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4275/6386744/e3d5114a66de/JGH3-3-17-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4275/6386744/50393bc01ce1/JGH3-3-17-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4275/6386744/6de089640fcc/JGH3-3-17-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4275/6386744/e3d5114a66de/JGH3-3-17-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4275/6386744/50393bc01ce1/JGH3-3-17-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4275/6386744/6de089640fcc/JGH3-3-17-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4275/6386744/e3d5114a66de/JGH3-3-17-g003.jpg

相似文献

1
Differences in the genetic backgrounds of patients with alcoholic liver disease and non-alcoholic fatty liver disease.酒精性肝病和非酒精性脂肪性肝病患者的遗传背景差异。
JGH Open. 2018 Oct 17;3(1):17-24. doi: 10.1002/jgh3.12097. eCollection 2019 Feb.
2
High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis.脂蛋白脂肪酶高产生变体可能对酒精相关性肝硬化中的肝细胞癌具有保护作用。
JHEP Rep. 2023 Jan 25;5(4):100684. doi: 10.1016/j.jhepr.2023.100684. eCollection 2023 Apr.
3
Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases.根据遗传背景和与生活方式相关疾病,日本非酒精性脂肪性肝病患者的结局。
Ann Hepatol. 2021 Mar-Apr;21:100260. doi: 10.1016/j.aohep.2020.09.004. Epub 2020 Sep 25.
4
Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression.经活检证实的日本非酒精性脂肪性肝病患者肝细胞癌的发生:PNPLA3基因分型与肝癌发生/纤维化进展之间的关联。
Hepatol Res. 2017 Oct;47(11):1083-1092. doi: 10.1111/hepr.12840. Epub 2016 Dec 15.
5
PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.载脂蛋白基因 I148M 多态性与肝细胞癌患者的临床表现和生存关系。
PLoS One. 2013 Oct 14;8(10):e75982. doi: 10.1371/journal.pone.0075982. eCollection 2013.
6
Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).遗传和表观遗传疾病修饰因子:非酒精性脂肪性肝病(NAFLD)和酒精性肝病(ALD)。
Transl Gastroenterol Hepatol. 2021 Jan 5;6:2. doi: 10.21037/tgh.2019.09.06. eCollection 2021.
7
Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver.PNPLA3基因单核苷酸多态性与脂肪肝、脂肪性肝炎及肝硬化的关联
Indian J Gastroenterol. 2017 Sep;36(5):366-372. doi: 10.1007/s12664-017-0784-y. Epub 2017 Oct 4.
8
PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.PNPLA3基因多态性与酒精性肝病的易感性及严重程度相关。
Am J Gastroenterol. 2015 Jun;110(6):846-56. doi: 10.1038/ajg.2015.137. Epub 2015 May 12.
9
Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.验证 PNPLA3 多态性作为混合人群非酒精性脂肪性肝病和肝纤维化的危险因素。
Ann Hepatol. 2019 May-Jun;18(3):466-471. doi: 10.1016/j.aohep.2018.10.004. Epub 2019 Apr 18.
10
as a Genetic Determinant of Risk for and Severity of Non-alcoholic Fatty Liver Disease Spectrum.作为非酒精性脂肪性肝病谱风险及严重程度的遗传决定因素。
J Clin Transl Hepatol. 2016 Sep 28;4(3):175-191. doi: 10.14218/JCTH.2016.00009. Epub 2016 Jul 8.

引用本文的文献

1
Metformin: Beyond Type 2 Diabetes Mellitus.二甲双胍:超越2型糖尿病
Cureus. 2024 Oct 17;16(10):e71730. doi: 10.7759/cureus.71730. eCollection 2024 Oct.
2
Analysis of genetic factors associated with fatty liver disease-related hepatocellular carcinoma.分析与脂肪性肝病相关的肝细胞癌相关的遗传因素。
Cancer Med. 2023 Sep;12(17):17798-17807. doi: 10.1002/cam4.6410. Epub 2023 Aug 29.
3
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease.饮酒与代谢相关脂肪性肝病(MAFLD)对进展性脂肪性肝病的双向影响。

本文引用的文献

1
KCNQ1 gene polymorphism is associated with glycaemic response to treatment with DPP-4 inhibitors.KCNQ1基因多态性与二肽基肽酶-4抑制剂治疗的血糖反应相关。
Diabetes Res Clin Pract. 2017 Aug;130:142-147. doi: 10.1016/j.diabres.2017.05.018. Epub 2017 May 19.
2
Association of β3-adrenergic receptor rs4994 polymorphisms with the risk of type 2 diabetes: A systematic review and meta-analysis.β3-肾上腺素能受体rs4994基因多态性与2型糖尿病风险的关联:一项系统评价和荟萃分析
Diabetes Res Clin Pract. 2017 Jul;129:86-96. doi: 10.1016/j.diabres.2017.03.034. Epub 2017 May 5.
3
The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation.
Ther Adv Endocrinol Metab. 2023 Jun 5;14:20420188231178370. doi: 10.1177/20420188231178370. eCollection 2023.
4
Patients with Non-Alcoholic Fatty Liver Disease and Alcohol Dehydrogenase 1B/Aldehyde Dehydrogenase 2 Mutant Gene Have Higher Values of Serum Alanine Transaminase.非酒精性脂肪性肝病患者与酒精脱氢酶1B/乙醛脱氢酶2突变基因携带者的血清丙氨酸转氨酶水平较高。
J Pers Med. 2023 Apr 28;13(5):758. doi: 10.3390/jpm13050758.
5
Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis.载脂蛋白 L3(rs738409) 多态性与非酒精性脂肪性肝病的关系: 系统评价和荟萃分析。
BMC Endocr Disord. 2021 Jun 19;21(1):125. doi: 10.1186/s12902-021-00789-4.
6
The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients.rs599839 A>G变异可区分非酒精性脂肪性肝病患者的心血管风险和肝细胞癌。
Cancers (Basel). 2021 Apr 8;13(8):1783. doi: 10.3390/cancers13081783.
7
The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome.酒精性肝病、肥胖与代谢综合征之间的相互作用
Visc Med. 2020 Jun;36(3):198-205. doi: 10.1159/000507233. Epub 2020 Apr 23.
与脂肪性肝病相关的PNPLA3变体(I148M)通过逃避泛素化作用而在脂滴上积累。
Hepatology. 2017 Oct;66(4):1111-1124. doi: 10.1002/hep.29273. Epub 2017 Aug 26.
4
A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients.KCNQ1 基因变异与瑞格列奈改善中国 2 型糖尿病患者胰岛素抵抗的疗效相关。
Sci Rep. 2016 Nov 18;6:37293. doi: 10.1038/srep37293.
5
Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.影响非酒精性脂肪性肝病的遗传因素:一项系统的临床综述。
World J Gastroenterol. 2016 Aug 7;22(29):6742-56. doi: 10.3748/wjg.v22.i29.6742.
6
Differential potassium channel gene regulation in BXD mice reveals novel targets for pharmacogenetic therapies to reduce heavy alcohol drinking.BXD小鼠中钾通道基因的差异调控揭示了减少大量饮酒的药物遗传学疗法的新靶点。
Alcohol. 2017 Feb;58:33-45. doi: 10.1016/j.alcohol.2016.05.007. Epub 2016 Jun 27.
7
PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.PNPLA3基因多态性与酒精性肝病的易感性及严重程度相关。
Am J Gastroenterol. 2015 Jun;110(6):846-56. doi: 10.1038/ajg.2015.137. Epub 2015 May 12.
8
Correlation between MTP -493G>T polymorphism and non-alcoholic fatty liver disease risk: a meta-analysis.MTP -493G>T基因多态性与非酒精性脂肪性肝病风险的相关性:一项荟萃分析
Genet Mol Res. 2014 Dec 4;13(4):10150-61. doi: 10.4238/2014.December.4.9.
9
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data.载脂蛋白基因 3(rs738409C>G)变体与肝细胞癌的关联:个体参与者数据荟萃分析的证据。
Hepatology. 2014 Jun;59(6):2170-7. doi: 10.1002/hep.26767. Epub 2014 Apr 25.
10
Genetics and alcoholism.遗传学与酗酒
Nat Rev Gastroenterol Hepatol. 2013 Aug;10(8):487-94. doi: 10.1038/nrgastro.2013.86. Epub 2013 May 28.